NVC-001 is designed to target the mechanobiological root cause of LMNA dilated cardiomyopathy and has disease-modifying potential SINGAPORE, PARIS and PHILADELPHIA, Oct. 8, 2026 /PRNewswire/ -- Nuevocor, a clinical-stage biotechnology company pioneering mechanobiology-targeted therapies designed to address the root causes of life-threatening cardiomyopathies, today announced that the first...
NEW YORK, May 29, 2026 /PRNewswire/ -- The enhanced fiber laser engraver lineup combines industrial-grade speed, precision, color marking, and deep metal engraving capabilities. ...
The partnership combines ECARX's system integration capabilities with TPK's optical manufacturing expertise. Production slated for 2028 at TPK's Thailand...
ADELAIDE, Australia, May 29, 2026 /PRNewswire/ -- As climate variability, drought pressure, and water scarcity continue to challenge agricultural productivity across Australia and the...
SHANGHAI, May 29, 2026 /PRNewswire/ -- Forbes has released its 2026 Midas List, the definitive ranking of the world's top venture capital investors. Alex...